A Clinical Trial to Assess the Absorption, Safety, and Efficacy of an Oral Nicotinamide Adenine Dinucleotide (NAD+) Supplement in Healthy Adults
- NCT ID
- NCT07692633
- Sponsor
- Reus Research
- Registry dates
- 2026-10-03 – 2027-03
- Enrollment
- 80 registered participants
- Locations
- Canada
- Conditions listed
- NAD+ Bioavailability; NAD+ Safety; NAD+ Efficacy
